Pharming Group (PHAR)
7.53
-0.23
(-2.96%)
USD |
NASDAQ |
Nov 22, 16:00
7.48
-0.05
(-0.66%)
After-Hours: 20:00
Pharming Group Shareholders Equity (Quarterly): 225.79M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 225.79M |
June 30, 2024 | 220.94M |
March 31, 2024 | 205.94M |
December 31, 2023 | 218.78M |
September 30, 2023 | 209.94M |
June 30, 2023 | 200.37M |
March 31, 2023 | 199.34M |
December 31, 2022 | 204.64M |
September 30, 2022 | 200.25M |
June 30, 2022 | 199.67M |
March 31, 2022 | 194.02M |
December 31, 2021 | 192.92M |
September 30, 2021 | 193.53M |
June 30, 2021 | 198.16M |
March 31, 2021 | 186.03M |
December 31, 2020 | 183.44M |
September 30, 2020 | 159.97M |
June 30, 2020 | 143.47M |
March 31, 2020 | 127.52M |
December 31, 2019 | 117.39M |
September 30, 2019 | 98.99M |
June 30, 2019 | 88.11M |
March 31, 2019 | 77.56M |
December 31, 2018 | 70.64M |
September 30, 2018 | 55.98M |
Date | Value |
---|---|
June 30, 2018 | 47.02M |
March 31, 2018 | 38.97M |
December 31, 2017 | 19.33M |
September 30, 2017 | 7.294M |
June 30, 2017 | 7.738M |
March 31, 2017 | 30.93M |
December 31, 2016 | 28.89M |
September 30, 2016 | 16.81M |
June 30, 2016 | 20.20M |
March 31, 2016 | 23.84M |
December 31, 2015 | 26.06M |
September 30, 2015 | 28.78M |
June 30, 2015 | 31.28M |
March 31, 2015 | 31.70M |
December 31, 2014 | 36.29M |
September 30, 2014 | 20.15M |
June 30, 2014 | 16.63M |
March 31, 2014 | 9.780M |
December 31, 2013 | 6.918M |
September 30, 2013 | -2.150M |
June 30, 2013 | -0.778M |
March 31, 2013 | -7.727M |
December 31, 2012 | -10.12M |
September 30, 2012 | -14.27M |
March 31, 2012 | -4.742M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
117.39M
Minimum
Dec 2019
225.79M
Maximum
Sep 2024
189.11M
Average
198.75M
Median
Shareholders Equity (Quarterly) Benchmarks
uniQure NV | 55.82M |
ProQR Therapeutics NV | 27.90M |
Merus NV | 703.26M |
argenx SE | -- |
Pharvaris NV | 331.48M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 425.51M |
Total Liabilities (Quarterly) | 199.72M |
Debt to Equity Ratio | 0.4226 |
Current Ratio | 3.534 |
Net Debt Paydown Yield | 1.45% |